John Thomas Wei
#144,678
Most Influential Person Now
John Thomas Wei's AcademicInfluence.com Rankings
John Thomas Weibiology Degrees
Biology
#10440
World Rank
#13770
Historical Rank
Computational Biology
#214
World Rank
#215
Historical Rank
Neuroscience
#1614
World Rank
#1665
Historical Rank
Biochemistry
#1645
World Rank
#1780
Historical Rank
Download Badge
Chemistry Biology
John Thomas Wei's Degrees
- PhD Biochemistry University of California, Berkeley
- Masters Chemistry Stanford University
- Bachelors Chemistry University of California, Berkeley
Why Is John Thomas Wei Influential?
(Suggest an Edit or Addition)John Thomas Wei's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression (2009) (1988)
- Radical prostatectomy versus observation for localized prostate cancer. (2012) (1359)
- Quality of life and satisfaction with outcome among prostate-cancer survivors. (2008) (1335)
- Update on AUA guideline on the management of benign prostatic hyperplasia. (2011) (1018)
- Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression (2011) (956)
- Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. (2005) (784)
- Integrative molecular concept modeling of prostate cancer progression (2007) (725)
- Urologic diseases in America project: benign prostatic hyperplasia. (2005) (691)
- Autoantibody signatures in prostate cancer. (2005) (606)
- TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. (2006) (488)
- Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. (2002) (456)
- A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range. (2011) (437)
- Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. (2006) (432)
- A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy. (2016) (430)
- Beyond PSA: The Next Generation of Prostate Cancer Biomarkers (2012) (417)
- Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. (2005) (388)
- Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. (2006) (376)
- Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA (2011) (364)
- Medical therapy to facilitate urinary stone passage: a meta-analysis (2006) (354)
- National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? (2006) (341)
- Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. (2010) (327)
- The role of SPINK1 in ETS rearrangement-negative prostate cancers. (2008) (327)
- A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. (2008) (323)
- Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer (2007) (319)
- Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. (2016) (318)
- Refractory idiopathic urge urinary incontinence and botulinum A injection. (2008) (303)
- A midurethral sling to reduce incontinence after vaginal prolapse repair. (2012) (286)
- Prediction of erectile function following treatment for prostate cancer. (2011) (284)
- Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer. (2006) (259)
- Identifying risk factors for potentially avoidable complications following radical cystectomy. (2005) (256)
- Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. (2006) (237)
- RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. (2014) (236)
- Can urinary PCA3 supplement PSA in the early detection of prostate cancer? (2014) (234)
- Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States (2009) (229)
- The prostate health index selectively identifies clinically significant prostate cancer. (2015) (228)
- Prostate cancer early detection. Clinical practice guidelines in oncology. (2010) (226)
- Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer. (2013) (211)
- Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer. (2014) (211)
- Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form. (2015) (207)
- A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [−2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer Aggressiveness (2010) (202)
- Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. (2003) (199)
- Contemporary epidemiology of bladder exstrophy in the United States. (2005) (181)
- Measuring health‐related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI) (2007) (174)
- Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. (2009) (171)
- Racial/ethnic disparities in the treatment of localized/regional prostate cancer. (2004) (160)
- Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. (2004) (156)
- NCCN clinical practice guidelines in oncology: prostate cancer early detection. (2010) (152)
- Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression (2018) (151)
- The role of sarcosine metabolism in prostate cancer progression. (2013) (150)
- Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study (2013) (147)
- Urologic diseases in america project: benign prostatic hyperplasia. (2008) (147)
- Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer. (2011) (143)
- Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men. (2015) (137)
- Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms. (2012) (137)
- Volume-based referral for cancer surgery: informing the debate. (2006) (136)
- The impact of co-morbid disease on cancer control and survival following radical cystectomy. (2003) (135)
- Nocturia and quality of life: results from the Boston area community health survey. (2012) (133)
- Functional Anatomy of the Pelvic Floor and Lower Urinary Tract (2004) (132)
- Decreased α-Methylacyl CoA Racemase Expression in Localized Prostate Cancer is Associated with an Increased Rate of Biochemical Recurrence and Cancer-Specific Death (2005) (131)
- Development and validation of the Bladder Cancer Index: a comprehensive, disease specific measure of health related quality of life in patients with localized bladder cancer. (2010) (126)
- Heterogeneity in Anatomic Outcome of Sacrospinous Ligament Fixation for Prolapse: A Systematic Review (2007) (116)
- Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument. (2003) (113)
- Surgical repair of bladder exstrophy in the modern era: contemporary practice patterns and the role of hospital case volume. (2005) (113)
- The increasing incidence of newborn circumcision: data from the nationwide inpatient sample. (2005) (111)
- Association Between Combined TMPRSS2: ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer (2017) (111)
- Evidence-based patient choice: a prostate cancer decision aid in plain language (2005) (110)
- The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the united states (2006) (106)
- The increasing incidence of congenital penile anomalies in the United States. (2005) (104)
- Patient Education Materials about the Treatment of Early-Stage Prostate Cancer: A Critical Review (2004) (103)
- Cancer survivorship: challenges and changing paradigms. (2008) (97)
- Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study. (2003) (97)
- Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men. (2006) (94)
- Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry. (2009) (92)
- Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference. (2006) (91)
- Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and Recurrence. (2016) (89)
- Effects of Aging on Lower Urinary Tract and Pelvic Floor Function in Nulliparous Women (2007) (89)
- The regionalization of radical cystectomy to specific medical centers. (2005) (88)
- A Novel RNA In Situ Hybridization Assay for the Long Noncoding RNA SChLAP1 Predicts Poor Clinical Outcome After Radical Prostatectomy in Clinically Localized Prostate Cancer12 (2014) (86)
- Transcriptome Sequencing Identifies PCAT-1, a Novel lincRNA Implicated in Prostate Cancer Progression (2011) (86)
- Temporal trends in the use of percutaneous nephrolithotomy. (2006) (83)
- Relationship of lifestyle and clinical factors to lower urinary tract symptoms: results from Boston Area Community Health survey. (2007) (81)
- Laparoscopy for renal cell carcinoma: diffusion versus regionalization? (2006) (80)
- The effects of adjusting for case mix on mortality and length of stay following radical cystectomy. (2006) (80)
- Correlation of urine TMPRSS2:ERG and PCA3 to ERG+ and total prostate cancer burden. (2012) (77)
- Variations in quality of care for men with early-stage prostate cancer. (2008) (77)
- Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms--what do we know? (2009) (75)
- Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer (2017) (74)
- Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men. (2002) (73)
- Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer. (2014) (70)
- Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy. (2015) (67)
- Elevated α-Methylacyl-CoA Racemase Enzymatic Activity in Prostate Cancer (2004) (67)
- Trends in the diffusion of laparoscopic nephrectomy. (2006) (66)
- Rational approach to implementation of prostate cancer antigen 3 into clinical care (2009) (66)
- Use of multiple imputation to correct for nonresponse bias in a survey of urologic symptoms among African-American men. (2002) (65)
- Humoral Response Profiling Reveals Pathways to Prostate Cancer Progression*S (2008) (64)
- Reliability of health-related quality-of-life measures 1 year after surgical procedures for pelvic floor disorders. (2005) (63)
- Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice. (2014) (63)
- Prospective multicenter evaluation of the Beckman Coulter Prostate Health Index using WHO calibration. (2013) (61)
- AUA White Paper on Nonneurogenic Chronic Urinary Retention: Consensus Definition, Treatment Algorithm, and Outcome End Points (2017) (60)
- Perineural invasion is a marker for pathologically advanced disease in localized prostate cancer. (2007) (59)
- Intraoperative nerve stimulation with measurement of urethral sphincter pressure changes during radical retropubic prostatectomy: a feasibility study. (2003) (58)
- Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator. (2015) (55)
- Complications and failure to rescue after laparoscopic versus open radical nephrectomy. (2011) (54)
- Quality of life issues in bladder cancer patients following cystectomy and urinary diversion. (2005) (53)
- Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection. (2009) (51)
- Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk (2012) (49)
- Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry. (2011) (49)
- Racial disparities in resource utilization for cystectomy. (2006) (49)
- Use of extended pattern technique for initial prostate biopsy. (2005) (48)
- Quality of care: partial cystectomy for bladder cancer--a case of inappropriate use? (2005) (48)
- The efficacy and safety of combined therapy with α-blockers and anticholinergics for men with benign prostatic hyperplasia: a meta-analysis. (2013) (48)
- Neoadjuvant hormonal therapy and older age are associated with adverse sexual health-related quality-of-life outcome after prostate brachytherapy. (2002) (47)
- Harnessing big data for health care and research: are urologists ready? (2014) (47)
- Utility of extended pattern prostate biopsies for tumor localization (2008) (47)
- Use of advanced treatment technologies among men at low risk of dying from prostate cancer. (2013) (46)
- Positional stability of electromagnetic transponders used for prostate localization and continuous, real-time tracking. (2007) (45)
- Discharge practice patterns following cystectomy for bladder cancer: evidence for the shifting of the burden of care. (2006) (45)
- The Michigan incontinence symptom index (M‐ISI): A clinical measure for type, severity, and bother related to urinary incontinence (2014) (45)
- Urine TMPRSS 2 : ERG Plus PCA 3 for Individualized Prostate Cancer Risk Assessment (2016) (44)
- Outcomes following vaginal prolapse repair and mid urethral sling (OPUS) trial—design and methods (2009) (44)
- Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population. (2011) (44)
- Effects of examination technique modifications on pelvic organ prolapse quantification (POP-Q) results (2003) (44)
- Cost‐effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer (2018) (44)
- Impact of surgical volume on mortality and length of stay after nephrectomy. (2004) (43)
- Evaluation of Tissue PCA3 Expression in Prostate Cancer by RNA in situ Hybridization - A Correlative Study with Urine PCA3 and TMPRSS2-ERG (2013) (43)
- Patient-reported sexual function after oral mucosa graft urethroplasty for hypospadias. (2005) (43)
- Long-term patient reported outcome and satisfaction after oral mucosa graft urethroplasty for hypospadias. (2005) (43)
- The effects of stage divergence on survival after radical cystectomy for urothelial cancer. (2005) (42)
- Incontinence Symptom Index-Pediatric: development and initial validation of a urinary incontinence instrument for the older pediatric population. (2007) (42)
- Partners’ Long-term Appraisal of Their Caregiving Experience, Marital Satisfaction, Sexual Satisfaction, and Quality of Life 2 Years After Prostate Cancer Treatment (2013) (42)
- Physician Ownership of Ambulatory Surgery Centers and Practice Patterns for Urological Surgery: Evidence from the State of Florida (2009) (42)
- Evaluating long-term patient-centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study (2013) (41)
- Bladder symptoms 1 year after abdominal sacrocolpopexy with and without Burch colposuspension in women without preoperative stress incontinence symptoms. (2007) (41)
- 2001 American Urological Association Gallup Survey: changes in physician practice patterns, satisfaction with urology, and treatment of prostate cancer and erectile dysfunction. (2002) (40)
- Comparing performance of Morbidity and Mortality Conference and National Surgical Quality Improvement Program for detection of complications after urologic surgery. (2006) (40)
- The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculator. (2013) (40)
- Development and validation of the convalescence and recovery evaluation (CARE) for measuring quality of life after surgery (2008) (39)
- Racial differences in serum prostate‐specific antigen (PSA) doubling time, histopathological variables and long‐term PSA recurrence between African‐American and white American men undergoing radical prostatectomy for clinically localized prostate cancer (2005) (39)
- Comparative analysis of urinary incontinence severity after autologous fascia pubovaginal sling, pubovaginal sling and tension-free vaginal tape. (2007) (38)
- Economic impact of surgical intervention in the treatment of benign prostatic hyperplasia. (2006) (37)
- Trends in medical management of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. (2013) (37)
- Patient, surgeon, and treatment characteristics associated with homologous blood transfusion requirement during radical retropubic prostatectomy: multivariate nomogram to assist patient counseling. (2004) (36)
- Effects of examination technique modifications on pelvic organ prolapse quantification (POP-Q) results (2003) (36)
- Population based trends in the surgical treatment of benign prostatic hyperplasia. (2012) (35)
- Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer. (2004) (35)
- Primary care perspectives on prostate cancer survivorship: implications for improving quality of care. (2013) (34)
- Use of quality indicators to evaluate the care of patients with localized prostate carcinoma (2003) (34)
- Quality of life and satisfaction among prostate cancer patients followed in a dedicated survivorship clinic (2015) (34)
- Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience. (2013) (34)
- The economic burden of prostate cancer survivorship care. (2010) (33)
- Variable reference alignment: an improved peak alignment protocol for NMR spectral data with large intersample variation. (2012) (32)
- Contemporary trends in surgical correction of pediatric ureteropelvic junction obstruction: data from the nationwide inpatient sample. (2005) (31)
- Obesity adversely affects health related quality of life before and after radical retropubic prostatectomy. (2006) (30)
- Regionalization of percutaneous nephrolithotomy: evidence for the increasing burden of care on tertiary centers. (2006) (30)
- Treatment Choice and Quality of Care for Men With Localized Prostate Cancer (2007) (29)
- Surgeon characteristics and long-term trends in the adoption of laparoscopic radical nephrectomy. (2011) (28)
- Risk factors for prolonged length of stay after urologic surgery: the National Surgical Quality Improvement Program. (2008) (28)
- Measuring the quality of care for localized prostate cancer. (2005) (28)
- Histotripsy Treatment of Benign Prostatic Enlargement Using the Vortx Rx System: Initial Human Safety and Efficacy Outcomes. (2018) (27)
- Comparative effectiveness of external-beam radiation approaches for prostate cancer. (2014) (27)
- Survivorship after prostate cancer treatment: spouses' quality of life at 36 months. (2013) (27)
- Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity. (2004) (27)
- Multiple prostate cancer cores with different Gleason grades submitted in the same specimen container without specific site designation: should each core be assigned an individual Gleason score? (2009) (26)
- Sexual Health Concerns Among Cancer Survivors: Testing a Novel Information-Need Measure Among Breast and Prostate Cancer Patients (2016) (26)
- Clinical research methods for surgeons (2007) (26)
- Selective detection of histologically aggressive prostate cancer (2012) (26)
- Anticholinergic versus botulinum toxin A comparison trial for the treatment of bothersome urge urinary incontinence: ABC trial. (2012) (26)
- Transperineal Template Guided Prostate Biopsy Selects Candidates for Active Surveillance--How Many Cores are Enough? (2015) (25)
- A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life. (2018) (24)
- External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life. (2017) (24)
- Health seeking behavior for lower urinary tract symptoms in black men. (2008) (24)
- Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study. (2013) (23)
- Non-surgical management of stress urinary incontinence: ambulatory treatments for leakage associated with stress (ATLAS) trial. (2008) (23)
- Contemporary preoperative parameters predict cancer-free survival after radical prostatectomy: a tool to facilitate treatment decisions. (2003) (23)
- Monitoring quality of life among prostate cancer survivors: the feasibility of automated telephone assessment. (2012) (23)
- Re: Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia (2011) (22)
- Development of a Nationally Representative Coordinated Registry Network for Prostate Ablation Technologies (2018) (22)
- Longitudinal changes in lower urinary tract symptoms among a cohort of black American men: the Flint Men's Health Study. (2004) (22)
- Risk factors for delayed hematuria following photoselective vaporization of the prostate. (2013) (22)
- Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. (2013) (22)
- Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists. (2009) (22)
- Comparison of validated instruments measuring sexual function in men. (2010) (21)
- Limitations of a contemporary prostate biopsy: the blind march forward. (2010) (21)
- Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancer. (2004) (21)
- Regionalization of care: centralizing complex surgical procedures (2005) (21)
- 2003 American Urological Association Gallup survey: physician practice patterns, cryosurgery/brachytherapy, male infertility, female urology and insurance/professional liability. (2004) (20)
- Body mass index and prostate cancer severity: do obese men harbor more aggressive disease on prostate biopsy? (2013) (20)
- Bladder exstrophy in the newborn: a snapshot of contemporary practice patterns. (2006) (20)
- Evaluation of point-of-care PRO assessment in clinic settings: integration, parallel-forms reliability, and patient acceptability of electronic QOL measures during clinic visits (2016) (20)
- Use of nephrectomy at select medical centers--a case of follow the crowd? (2006) (20)
- Early urinary retention after catheter removal following radical prostatectomy predicts for future symptomatic urethral stricture formation. (2007) (20)
- Satisfaction with information used to choose prostate cancer treatment. (2014) (20)
- Urologist practice styles in the initial evaluation of elderly men with benign prostatic hyperplasia. (2011) (20)
- Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer (2015) (19)
- Certificate of need legislation and the dissemination of robotic surgery for prostate cancer. (2013) (19)
- Are persistent or recurrent symptoms of urinary incontinence after surgery associated with adverse effects on sexual activity or function? (2007) (19)
- Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study (2017) (18)
- Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8. (2010) (18)
- Quantifying Gleason scores with photoacoustic spectral analysis: feasibility study with human tissues. (2015) (18)
- Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator. (2019) (18)
- Preoperative and intraoperative risk factors associated with 30-day morbidity following urological surgery: the National Surgical Quality Improvement Program. (2006) (17)
- Disparities in the use of ambulatory surgical centers: a cross sectional study (2009) (17)
- Postoperative complications and long-term survival among patients treated surgically for renal cell carcinoma. (2012) (16)
- Artificial neural networks for prostate carcinoma risk assessment (2000) (16)
- Interstitial assessment of aggressive prostate cancer by physio‐chemical photoacoustics: An ex vivo study with intact human prostates (2018) (16)
- Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy. (2013) (16)
- Adoption of new technology and healthcare quality: surgical margins after robotic prostatectomy. (2007) (16)
- Use of the MyProstateScore (MPS) Test to Rule Out Clinically-Significant Cancer: Validation of a Straightforward Clinical Testing Approach. (2020) (15)
- Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancer (2018) (15)
- Complex cellular composition of solitary fibrous tumor of the prostate. (2014) (15)
- A screening tool for clinically relevant urinary incontinence (2015) (15)
- Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment (2017) (15)
- Sexual health recovery after prostatectomy, external radiation, or brachytherapy for early-stage prostate cancer (2004) (14)
- Changes in physical activity after abdominal sacrocolpopexy for advanced pelvic organ prolapse. (2008) (14)
- Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter Study (2017) (14)
- Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy series (2014) (13)
- Differential adoption of laser prostatectomy for treatment of benign prostatic hyperplasia. (2012) (13)
- A MID URETHRAL SLING PREVENTS INCONTINENCE AMONG WOMEN UNDERGOING VAGINAL PROLAPSE REPAIR– THE OPUS TRIAL (2011) (13)
- Understanding prostate cancer spending growth among Medicare beneficiaries. (2011) (13)
- Sexual health recovery after prostatectomy, external radiation, or brachytherapy for early stage prostate cancer (2004) (12)
- Local anesthesia in transrectal prostate biopsy. (2006) (12)
- The use of tumor markers in testis cancer in the United States: a potential quality issue. (2008) (12)
- Technology diffusion and diagnostic testing for prostate cancer. (2013) (12)
- Weekend admission and treatment of patients with renal colic: a case of avoidable variation? (2009) (12)
- PD46-02 MULTICENTER EVALUATION OF THE PROSTATE HEALTH INDEX (PHI) FOR DETECTION OF AGGRESSIVE PROSTATE CANCER IN BIOPSY-NAÏVE MEN (2015) (12)
- Non-surgical management of stress urinary incontinence: ambulatory treatments for leakage associated with stress (ATLAS) trial (2007) (12)
- Understanding Inpatient Cost Variation in Kidney Transplantation: Implications for Payment Reforms. (2016) (12)
- Changes in initial expenditures for benign prostatic hyperplasia evaluation in the Medicare population: a comparison to overall Medicare inflation. (2012) (12)
- A Comparison of Extraperitoneal and Intraperitoneal Approaches for Robotic Prostatectomy (2012) (11)
- Radical cystectomy and surgical quality of care. (2005) (11)
- Patient-Reported Recovery After Abdominal and Pelvic Surgery Using the Convalescence and Recovery Evaluation (CARE): Implications for Measuring the Impact of Surgical Processes of Care and Innovation (2009) (11)
- Shared decision-making strategies for early prostate cancer. (2002) (11)
- Does urethral competence affect urodynamic voiding parameters in women with prolapse? (2007) (11)
- Refractory Urge Urinary Incontinence and Botulinum A Injection: The Methods of the RUBI Trial (2006) (10)
- Urinary incontinence after stress incontinence surgery: a risk factor for depression. (2009) (10)
- Urologists and the patient centered medical home. (2010) (10)
- Concurrent assessment of obstructive/irritative urinary symptoms and incontinence after radical prostatectomy. (2002) (10)
- Artificial neural networks for prostate carcinoma risk assessment (2001) (10)
- Optimizing active surveillance strategies to balance the competing goals of early detection of grade progression and minimizing harm from biopsies (2018) (10)
- NMR-Based Metabolomic Profiling of Urine: Evaluation for Application in Prostate Cancer Detection (2019) (10)
- The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer. (2010) (10)
- Formation of an orthotopic neobladder following radical cystectomy:: Historical perspective, patient selection, and contemporary outcomes (2002) (9)
- Two-Stage Biomarker Protocols for Improving the Precision of Early Detection of Prostate Cancer (2017) (9)
- Physical activity in women planning sacrocolpopexy (2006) (9)
- Medicare reimbursement changes for ambulatory surgery centers and remuneration to urological physician-owners. (2008) (9)
- Managed care and the diffusion of intensity-modulated radiotherapy for prostate cancer. (2012) (9)
- Certificate of need regulations and the diffusion of intensity-modulated radiotherapy. (2012) (9)
- Development and Validation of a Quantitative Measure of Adaptive Behaviors in Women With Pelvic Floor Disorders. (2017) (9)
- Evaluative care guideline compliance is associated with provision of benign prostatic hyperplasia surgery. (2012) (9)
- Treatment Availability Influences Physicians’ Portrayal of Robotic Surgery During Clinical Appointments (2017) (8)
- Screening for Prostate Cancer—Beyond Total PSA, Utilization of Novel Biomarkers (2015) (8)
- Does the combination of an α1-adrenergic antagonist with a 5α-reductase inhibitor improve urinary symptoms more than either monotherapy? (2010) (8)
- Outcomes of native tissue transvaginal apical approaches in women with advanced pelvic organ prolapse and stress urinary incontinence (2020) (8)
- Relevant patient and tumor considerations for early prostate cancer treatment. (2002) (8)
- Assessment of the quality of medical care among patients with early stage prostate cancer undergoing expectant management in the United States. (2012) (8)
- The association of Incontinence Symptom Index scores with urethral function and support. (2008) (8)
- 1847 [-2]PROPSA IN COMBINATION WITH PSA AND FREE-PSA, USING THE BECKMAN COULTER ACCESS IMMUNOASSAY SYSTEMS IMPROVES PROSTATE CANCER DETECTION RELATIVE TO PSA AND FREE PSA. A MULTI-CENTER PROSPECTIVE CLINICAL STUDY (2010) (7)
- Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology (2015) (7)
- Noninvasive Detection of TMPRSS 2 : ERG Fusion Transcripts in the Urine of Men with Prostate Cancer 1 (2014) (7)
- Abstract 4707: Discovery and characterization of PCAT-1, a novel lincRNA implicated in prostate cancer tumorigenesis (2011) (7)
- Anticipating the Impact of Insurance Expansion on Inpatient Urological Surgery (2014) (7)
- Urinary biomarkers for prostate cancer (2015) (7)
- Implant experience and positional stability of AC magnetic beacon™ transponders used to localize patients for external beam radiation therapy of the prostate (2004) (7)
- 1185: Long-Term Outcomes Among Localized Prostate Cancer Survivors: HRQOL Changes 4 to 8 Years Following Brachytherapy, External Radiation and Radical Prostatectomy (2004) (7)
- Quality of care and performance-based reimbursement: the contemporary landscape and implications for urologists. (2006) (7)
- Development of the Measure of Adaptations for Pelvic Symptoms (MAPS): the Importance of Incorporating the Female Patient’s Voice (2007) (7)
- Assessing the Performance and Validity of Diagnostic Tests and Screening Programs (2006) (7)
- Corrigendum: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression (2013) (7)
- Original Articles BCL-2 AND P53 EXPRESSION IN CLINICALLY LOCALIZED PROSTATE CANCER PREDICTS RESPONSE TO EXTERNAL BEAM RADIOTHERAPY (1999) (7)
- PROSTATE CANCER DETECTION USING A NOVEL COMPUTERIZED THREE-DIMENSIONAL PROSTATE BIOPSY TEMPLATE (TARGETSCAN™): RESULTS OF A MULTICENTER PROSPECTIVE DATA REGISTRY (2009) (6)
- 552: Patient-Reported Outcomes after Retropubic, Laparoscopic, or Robot-Assisted Prostatectomy: Results from a Prospective, Multi-Center Study (2007) (6)
- 137: Regionalization of Radical Cystectomy (2004) (6)
- The correlation of voiding variables between non‐instrumented uroflowmetery and pressure‐flow studies in women with pelvic organ prolapse (2008) (6)
- Urinary TMPRSS2: Use of ERG and PCA3 to predict tumor volume and Gleason grade in an active surveillance cohort-Results from the Canary/EDRN Prostate Active Surveillance Study. (2012) (6)
- Interpositional Nerve Grafting of the Prostatic Plexus after Radical Prostatectomy (2015) (5)
- 1151: Perioperative Quality Care Indicators of Retropubic, Laparoscopic, and Robotic Prostatectomy: Results from a National, Multi-Center, Prospective Cohort (2006) (5)
- SIGNIFICANCE OF TERTIARY PATTERN 5 IN PROSTATE NEEDLE BIOPSIES WITH GLEASON SCORE OF 3+4 OR 4+3 PROSTATE CANCER: PATHOLOGIC CORRELATION FOLLOWING RADICAL PROSTATECTOMY (2009) (5)
- Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer (BJU International (2008) 102 (546-50) (2009) (5)
- Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy series. (2014) (5)
- Patient-reported sexual function after oral mucosa graft urethroplasty for hypospadias: Commentary (2005) (5)
- Factors Associated With Urge Urinary Incontinence After Surgery for Stress Urinary Incontinence (2011) (5)
- Head to head randomized trial of two decision aids for prostate cancer (2019) (5)
- Photoacoustic spectral analysis at ultraviolet wavelengths for characterizing the Gleason grades of prostate cancer. (2020) (5)
- 7: Differences in Medical Management of LUTS/BPH between PCPS and Urologists (2006) (5)
- Development and Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite Instrument (EPIC-26) for Measuring Health-Related Quality of Life Among Prostate Cancer Survivors (2011) (5)
- Expanded Prostate Cancer Index Composite--Short Form (2020) (5)
- Preparing Patients with Early Stage Prostate Cancer to Participate in Clinical Appointments Using a Shared Decision Making Training Video (2021) (5)
- The role of prostate specific antigen in screening and management of clinically localized prostate cancer (2004) (5)
- 18: Measuring Quality-of-Life after Surgery: Development and Validation of the Convalescence and Recovery Evaluation (CARE) (2007) (4)
- Urinary TMPRSS2: Use of ERG and PCA3 to predict tumor volume and Gleason grade in an active surveillance cohort-Results from the Canary/EDRN Prostate Active Surveillance Study. (2012) (4)
- BLADDER NECK-SPARING TECHNIQUE ADVERSELY AFFECTS ANTI-TUMOR EFFICACY OF RADICAL PROSTATECTOMY IN PATHOLOGIC T3a PROSTATE CANCER (1999) (4)
- 11: Impact of Prostate Cancer Patient Treatment Outcome on HRQOL and Satisfaction with Cancer Care among Their Spouses (2007) (4)
- 36: Measuring Health-Related Quality of Outcomes in Bladder Cancer Patients using the Newly Validated Bladder Cancer Index (BCI) (2006) (4)
- Editorial: Understanding the Pathophysiology of Stress Urinary Incontinence (1996) (4)
- Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium (2021) (4)
- Temporary Health Impact of Prostate MRI and Transrectal Prostate Biopsy in Active Surveillance Prostate Cancer Patients. (2019) (4)
- FACTORS ASSOCIATED WITH CHANGES IN BENIGN PROSTATIC HYPERPLASIA (BPH) MANAGEMENT IN CLINICAL PRACTICE: LONGITUDINAL RESULTS FROM THE BPH REGISTRY (2008) (4)
- GENDER DIFFERENCES IN URINARY FUNCTION AFTER ORTHOTOPIC NEOBLADDER (1999) (4)
- Trends in Surgical Management of Benign Prostatic Hyperplasia (2011) (4)
- PII-LBA2 VALIDATION OF A NOVEL NON-INVASIVE URINE EXOSOME GENE EXPRESSION ASSAY TO PREDICT HIGH-GRADE PROSTATE CANCER IN PATIENTS UNDERGOING INITIAL BIOPSY WITH AN EQUIVOCAL PSA. (2015) (3)
- 35: Development and Validation of the Bladder Cancer Index (BCI): A Disease Specific Measure of Quality of life (2006) (3)
- 6: Differences Between PCPS and Urologists in the Evaluation of Men with LUTS/BPH (2006) (3)
- 1907 INCONTINENCE-RELATED OUTCOMES FOLLOWING PHOTOSELECTIVE VAPORIZATION OF (2010) (3)
- PCA3 AND TMPRSS:ERG ASSESSMENT IN SEMEN: RESULTS OF A PHASE I STUDY (2020) (3)
- COMMENT ON: OSTEOPOROSIS AFTER ORCHIECTOMY FOR PROSTATE CANCER (1998) (3)
- Urinary MyProstateScore (MPS) to rule out clinically-significant cancer in men with equivocal (PI-RADS 3) multiparametric MRI: addressing an unmet clinical need. (2021) (3)
- ACCURACY OF CLAIMS DATA TO IDENTIFY INCIDENT CASES OF BENIGN PROSTATIC HYPERPLASAI (2008) (3)
- RECOVERY AFTER ABDOMINAL AND PELVIC SURGERY (2008) (3)
- Development of the Japanese version of the health‐related quality of life questionnaire for bladder cancer patients using the Bladder Cancer Index: A pilot study (2019) (3)
- URINE PROSTATE CANCER GENE 3 ASSAY FOR RISK STRATIFICATION AND IMPROVED PREDICTION FOR PROSTATE CANCER (2008) (3)
- 2106 BODY MASS INDEX AND PROSTATE SIZE IMPROVE PERFORMANCE OF A PROSTATE CANCER RISK CALCULATOR AT HIGH LEVELS OF SENSITIVITY FOR PREDICTING PROSTATE CANCER AT INITIAL PROSTATE BIOPSY: RESULTS FROM A PROSPECTIVE, MULTI-CENTER COHORT (2010) (2)
- Association of Urinary MyProstateScore, Age, and Prostate Volume in a Longitudinal Cohort of Healthy Men: Long-term Findings from the Olmsted County Study (2021) (2)
- Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer. (2021) (2)
- 827: Salvage Therapy Adversely Effects Long-Term Hrqol among Localized Prostate Cancer Treatment Survivors (2005) (2)
- Analysis of the androgen receptor–regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression (2018) (2)
- 954: Effect of Benign Prostatic Hyperplasia Management on Ejaculatory Function: Longitudinal Data from the BPH Registry & Patient Survey (2007) (2)
- Prostate biopsies: How well do they predict tumor location? (2006) (2)
- Photoacoustic biopsy: a feasibility study (2015) (2)
- Potential Savings in Medicare Part D for Common Urological Conditions (2017) (2)
- Investigating the long noncoding RNA SChLAP1 as a prognostic tissue and urine biomarker in prostate cancer. (2015) (2)
- 1436: Comprehensive Assessment of TMPRSS2 and ETS Family Gene Aberrations in Clinically Localized Prostate Cancer (2007) (2)
- 999 SELECTIVE DETECTION OF HISTOLOGICALLY AGGRESSIVE PROSTATE CANCER: VALIDATION BY PCPT COHORT DATA OF AN EDRN PREDICTIVE MODEL TO REDUCE UNNECESSARY PROSTATE BIOPSIES (2011) (2)
- 175: Regionalization of Partial and Radical Nephrectomy to Specific Medical Centers (2005) (2)
- MP58-15 VARIATION IN USE OF ACTIVE SURVEILLANCE AMONG MEN UNDERGOING EXPECTANT MANAGEMENT OF EARLY-STAGE PROSTATE CANCER (2014) (2)
- Health related quality of life following 3D conformal external beam radiotherapy: treatment factors influence patient-reported outcome (2000) (2)
- 2055 PROSTATE HEALTH INDEX (PHI) FOR REDUCING OVERDETECTION OF INDOLENT PROSTATE CANCER AND UNNECESSARY BIOPSY WHILE IMPROVING DETECTION OF AGGRESSIVE CANCERS (2013) (2)
- Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP): Development and Validation of a Practical Health- Related Quality of Life Instrument for Use in the Routine Clinical Care of Prostate Cancer Patients (2013) (2)
- Testing-Related Health Impact of Transrectal and Transperineal Prostate Biopsy as Assessed by Health Utilities (2021) (2)
- CHANGES IN LOWER URINARY TRACT SYMPTOMS (LUTS) IN MEN RECEIVING MEDICAL THERAPY FOR BENIGN PROSTATIC HYPERPLASIA (BPH): LONGITUDINAL OUTCOMES FROM THE BPH REGISTRY (2008) (2)
- Introduction of laser technology and procedure use for benign prostatic hyperplasia: data from Florida. (2012) (2)
- Health-Related Quality of Life Issues (2004) (2)
- MEDICAL MANAGEMENT OF LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA (LUTS/ BPH): DIFFERENCES BETWEEN UROLOGISTS AND PRIMARY CARE PHYSICIANS (PCPS) (2006) (2)
- Caveats for modeling disease free survival after radical prostatectomy (2000) (2)
- Nomination and validation of the long noncoding RNA SChLAP1 as a risk factor for metastatic prostate cancer progression: a multi-institutional high-throughput analysis (2015) (2)
- Health-related quality of life in Japanese patients with bladder cancer measured by a newly developed Japanese version of the Bladder Cancer Index (2020) (2)
- 909: Neoadjuvant Hormone Therapy Impairs Long-term Sexual Outcome Among Younger Men that Undergo External Beam Radiotherapy for Localized Prostate Cancer (2004) (1)
- Evaluation of Gleason scores by photoacoustic spectral analysis (2015) (1)
- MP26-07 IN-OFFICE FREEHAND TRANSPERINEAL TEMPLATE MAPPING BIOPSY PERFORMED UNDER LOCAL ANESTHESIA USING A NOVEL NEEDLE GUIDE: FEASIBLE, SAFE, AND EFFECTIVE FOR CANCER DETECTION (2018) (1)
- 134: The Rising Rate of Newborn Circumcision (2004) (1)
- Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen. (2021) (1)
- Detection of Prostate Cancer in First-Generation Chinese Men. (1998) (1)
- 2: Contemporary Practice Patterns in Management of Bladder Exstrophy in Newborns (2005) (1)
- Impact of the MyProstateScore (MPS) test on the clinical decision to undergo prostate biopsy: results from a contemporary academic practice (2020) (1)
- 498 HIGH RATES FOR CONTINUED BPH MEDICAL THERAPY AMONG NON RESPONDERS (2010) (1)
- Availability of In‐Office Laboratory Services and Use of Prostate Specific Antigen Testing (2014) (1)
- 126: Metabolic Syndrome and Risk of Prostate Cancer: Nhanes 2001-2002 (2006) (1)
- MP43-05 FREEHAND TRANSPERINEAL BIOPSY SAMPLING STRATEGIES: WHAT IS THE OPTIMAL TEMPLATE? (2021) (1)
- Abstract 2815: Urine TMPRSS2:ERG for prostate cancer risk stratification in men with elevated serum PSA (2011) (1)
- MP40-13 OPTIMIZED CLINICAL ALGORITHM TO COMBINE TESTING OF SERUM PHI AND URINARY PCA3 TO IMPROVE PROSTATE CANCER DETECTION BY REDUCING UNNECESARY BIOPSY (2018) (1)
- Impact of the MyProstateScore (MPS) test on the clinical decision to undergo prostate biopsy: results from a contemporary academic practice. (2020) (1)
- MP6-13 INSURANCE EXPANSION AND THE UTILIZATION OF INPATIENT UROLOGICAL SURGERY (2014) (1)
- Abstract 899: TMPRSS2:ERG urine test identifies Gleason score upgrading and significant prostate cancer (2011) (1)
- 982 EVALUATION OF THE PROSTATE HEALTH INDEX (PHI)1 IN THE 2 TO 4, AND 4 TO 10 NG/ML PSA RANGES: RESULTS FROM A MULTI-SITE, PROSPECTIVE, CLINICAL EVALUATION (2011) (1)
- The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States (2006) (1)
- PI-08 COMBINING URINE PCA3 AND TMPRSS2: ERG TESTS TO REFINE PROSTATE CANCER DETECTION – VALIDATION STUDY AND HEALTH ECONOMIC ANALYSIS (2015) (1)
- MP76-06 USE AND EFFECTIVENESS OF PHARMACOLOGIC AND NON-PHARMACOLOGIC ERECTILE AIDS AMONG POST-PROSTATECTOMY PROSTATE CANCER SURVIVORS SEEKING TREATMENT FOR ERECTILE DYSFUNCTION: A PROSPECTIVE, MULTICENTER STUDY (2016) (1)
- SOCIO-ECONOMIC STATUS PREDICTS UTILIZATION OF AMBULATORY SURGERY CENTERS (2008) (1)
- 136: Is Race a Surrogate for the Differences in Income in Men with Clinically Localized Prostate Cancer? (2004) (1)
- MP18-10 MI TREXIT: PILOT EVALUATION OF A STATE-WIDE INITIATIVE FOR IN-OFFICE TRANSPERINEAL VERSUS TRANSRECTAL PROSTATE BIOPSY UNDER LOCAL ANESTHESIA (2019) (1)
- Characterizing the aggressiveness of prostate cancer using an all-optical needle photoacoustic sensing probe: feasibility study. (2021) (1)
- Appendix. Pelvic Floor Disorders Network Members (2008) (1)
- MP26-12 USE OF THE MYPROSTATESCORE (MPS) TEST FOR RISK STRATIFICATION IN MEN WITH A PREVIOUS NEGATIVE BIOPSY: INITIAL VALIDATION OF A STRAIGHTFORWARD TESTING APPROACH (2021) (1)
- Contemporary measures for the assessment of health-related quality of life in prostate cancer (2001) (1)
- EFFECT OF PHOSPHODIESTERASE TYPE 5 INHIBITOR USE ON LOWER URINARY TRACT SYMPTOMS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA (BPH): RESULTS FROM THE BPH REGISTRY (2008) (1)
- 1033: The Quality of Surgical Pathology Care for Men Treated with Radical Prostatectomy in the United States (2007) (1)
- [-2]PROPSA FOR PROSTATE CANCER DETECTION: A PROSPECTIVE, MULTICENTER, NCI EARLY DETECTION RESEARCH NETWORK STUDY (2009) (1)
- 173: Quantifying the Public Health Impact of Low Hospital Volume on Surgical Outcomes in the Treatment of Urologic Malignancies (2005) (1)
- 2204: Early Complications Following Contemporary Brachytherapy for Prostate Cancer in a Multi-Institutional Study at High Volume Health Centers in the US (2006) (1)
- TMPRSS2-ERG FUSION PROSTATE CANCER PREVALENCE, ASSOCIATION WITH PSA DENSITY, AND HISTOLOGIC FEATURES IN A MULTI-CENTER U.S. COHORT OF MEN UNDERGOING PROSTATE BIOPSY (2008) (1)
- Comparing current care to the NCCN prostate cancer practice guidelines (1999) (1)
- PD34-03 TIMING OF THE CONFIRMATORY BIOPSY IN PROSTATE CANCER ACTIVE SURVEILLANCE: ANALYSIS OF THE CANARY PROSTATE CANCER ACTIVE SURVEILLANCE STUDY (PASS) (2015) (1)
- PD38-08 MULTI-INSTITUTIONAL PROSPECTIVE VALIDATION OF THE NOVEL MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE TRANSPERINEAL BIOPSY TEMPLATE (2020) (1)
- Abstract 29: LONG-TERM FOLLOW UP OF INTERPOSITIONAL NERVE GRAFTING OF THE PROSTATIC PLEXUS AFTER OPEN PROSTATECTOMY (2013) (1)
- Re: The increasing incidence of newborn circumcision: Data from the nationwide inpatient sample [6] (multiple letters) (2006) (1)
- 1772: Prostate Size, Obesity, and Neoadjuvant Hormone Therapy affect Hrqol in a Prospective, Multi-Center Study of Prostatectomy, External Radiotherapy, or Brachytherapy for Prostate Cancer (2007) (1)
- COMPARISON OF VALIDATED INSTRUMENTS TO MEASURE SEXUAL FUNCTION IN A COHORT OF PREOPERATIVE PROSTATE CANCER PATIENTS (2008) (1)
- Is the Fear of Postprostatectomy Radiation Therapy Justified?: An Analysis of Patient-Reported Quality of Life Following Adjuvant or Salvage Radiation (2014) (1)
- Prostate cancer and the educated consumer. (2002) (1)
- MP11-09 TRANSPERINEAL TEMPLATE-GUIDED PROSTATE BIOPSY IN PATIENTS INITIATING ACTIVE SURVEILLANCE: A MULTI-INSTITUTIONAL COMPARISON (2015) (0)
- Incontinence urgery : A Risk Factor for Depression (0)
- 125 THE DISSEMINATION OF INTENSITY-MODULATED RADIOTHERAPY AND ROBOTIC PROSTATECTOMY AMONG MEN AT LOW RISK OF DYING FROM PROSTATE CANCER (2013) (0)
- 473: Racial Variations in the Utilization of Pelvic Lymph Node Dissection in Men Receiving a Radical Prostatectomy for Localized/Regional Prostate Cancer (2004) (0)
- 454: Effects of Brachytherapy on Racial Treatment Trends in Localized/Regional Prostate Cancer: Contemporary Data from SEER (2004) (0)
- MP43-15 PROVIDER VARIATION IN PAIN SCORES DURING FREEHAND TRANSPERINEAL PROSTATE BIOPSY UNDER LOCAL ANESTHESIA (2021) (0)
- 2091 DELAYED HEMATURIA FOLLOWING PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE (2010) (0)
- MP17-11 REFINEMENT AND EXTERNAL VALIDATION OF A NOVEL MULTIPLEX URINE TEST FOR HIGH-GRADE PROSTATE CANCER (2023) (0)
- 1132 THE EXPANDED PROSTATE CANCER INDEX COMPOSITE FOR CLINICAL PRACTICE (EPIC-CP) IS SENSITIVE TO TREATMENT-RELATED QUALITY OF LIFE CHANGES OVER TIME VALIDATION USING THE PROST-QA COHORT (2012) (0)
- REAL-TIME HEALTH-RELATED QUALITY OF LIFE ASSESSMENT AMONG PROSTATE CANCER SURVIVORS (2009) (0)
- Comparison of treatment modalities for localized prostate cancer using quality-of-life measures (2008) (0)
- 441 PATIENT RECOVERY AND QUALITY OF LIFE AFTER RADICAL CYSTECTOMY: COMPARISON OF OPEN VERSUS ROBOTIC APPROACHES (2013) (0)
- PD38-09 UROLOGIST-LEVEL VARIATION IN CANCER DETECTION WITH MR/US FUSION BIOPSY (2020) (0)
- PD53-01 DEVELOPMENT OF A WHOLE-URINE, MULTIPLEXED, NEXT GENERATION RNA-SEQUENCING ASSAY FOR AGGRESSIVE PROSTATE CANCER EARLY DETECTION (2020) (0)
- 133: Factors Associated with Increased Resource Utilization Following Radical Cystectomy (2004) (0)
- PD65-10 URINARY MYPROSTATESCORE (MPS) TO RULE OUT CLINICALLY-SIGNIFICANT CANCER IN MEN WITH EQUIVOCAL (PI-RADS 3) MULTIPARAMETRIC MRI: ADDRESSING AN UNMET CLINICAL NEED (2021) (0)
- How much worse will my voiding symptoms get over time? (2014) (0)
- Ability of an epigenetic assay to identify anterior prostate tumors based on a negative 12-core biopsy. (2016) (0)
- 1812 SURGEON VARIANCE IN PATIENT-REPORTED AND CLINICAL OUTCOMES OF RETROPUBIC, LAPAROSCOPIC, OR ROBOTIC RADICAL PROSTATECTOMY (2012) (0)
- MP20-15 PROSPECTIVE EVALUATION OF A NOVEL TRANSPERINEAL ELECTROMAGNETICALLY-TRACKED MR/US FUSION BIOPSY SYSTEM (2019) (0)
- 1634 TRANSPERINEAL MAPPING TEMPLATE PROSTATE BIOPSY ADDRESSES UNDER SAMPLING FOR MEN CONSIDERING ACTIVE SURVEILLANCE (2011) (0)
- Neoadjuvant Hormone Therapy (NHT) Leads to Immediate Impairment of Vitality/Hormonal and Sexual Quality of Life: Results of a Multi-Center Prospective Study (2005) (0)
- Tomlins Men with Elevated Serum PSA Fusion Transcript Stratifies Prostate Cancer Risk in TMPRSS 2 : ERG Urine (2011) (0)
- MP-09.17: Differences between PCPs and urologists in the medical treatment of men with LUTS/BPH (2006) (0)
- ECONOMIC IMPLICATIONS OF UROLOGIST PRESCRIPTION PRACTICES AMONG MEDICARE PART D BENEFICIARIES: PD14‐05 (2017) (0)
- 1818 COMPARATIVE EFFECTIVENESS OF EXTERNAL BEAM RADIATION APPROACHES FOR PROSTATE CANCER (2012) (0)
- Health-related quality of life in Japanese patients with bladder cancer according to a newly developed Japanese version of the Bladder Cancer Index. (2020) (0)
- 670: Contemporary Trends in Pediatric Pyeloplasty: Data from the National Inpatient Survey (2004) (0)
- 349 QUALITY AND INTENSITY OF EVALUATIVE CARE ARE ASSOCIATED WITH PROVISION OF BPH SURGERY (2010) (0)
- Label free aggressive prostate cancer identification with ultraviolet photoacoustic spectral analysis (Conference Presentation) (2017) (0)
- 21 PCA3 and PCA3/TERG add further predictive value to the PCPT risk calculator amongst non-African American men, but not amongst African Americans in the Early Detection Research Network (EDRN) (2015) (0)
- A Generalized Assessment of the Impact of Regionalization and Provider Learning on Patient Outcomes (2016) (0)
- 2122 CAN TRANSPERINEAL MAPPING TEMPLATE PROSTATE BIOPSY ADEQUATELY PREDICT PROSTATE CANCER LOCALIZATION (2011) (0)
- LONG-TERM ADHERENCE TO USE OF 5-α REDUCTASE INHIBITORS AND α-ADRENERGIC RECEPTOR INHIBITORS (2009) (0)
- 221: Sociodemographic Variation in the use of Information Among Prostate Cancer Patients (2006) (0)
- 1547: Health-Seeking Behavior and Lower Urinary Tract Symptoms among a Cohort of African-American Men: The Flint Men's Healthstudy (2004) (0)
- 1597: Local Therapies for Low-Risk Prostate Cancer: Exploring the Potential Burden of Overtreatment (2006) (0)
- 388: Determinants of Patient Satisfaction Following Contemporary Therapy for Localized Prostate Cancer: Characterizing the Quality of Cancer Care and the Clinical Relevance of Long-Term HRQOL Outcomes (2004) (0)
- 1128: The Effect of Hospital Type and Case Volume on the Delivery of Radiation Therapy for Localized Prostate Cancer: Insight From an American College of Surgeons Special Study (2006) (0)
- Expanded Prostate Cancer Index Composite Questionnaire (2018) (0)
- Conference on Prognostic Factors and Staging in Cancer Management: Contributions of Artificial Neural Networks and Other Statistical Methods (2001) (0)
- 143 TRENDS AND VARIATION IN MEDICAL MANAGEMENT OF MEN WITH BENIGN PROSTATIC HYPERPLASIA AND LOWER URINARY TRACT SYMPTOMS (1993-2010) (2013) (0)
- MP6-02 LOCATION OF DISEASE DOES NOT IMPACT PCA3'S ABILITY TO PREDICT CANCER ON BIOPSY (2015) (0)
- Ureteroscopy: Medical therapy to facilitate urinary stone passage: A meta-analyis - Commentary (2007) (0)
- 99: Prevalence of and Risk Factors for Prostatitis in African American Men: The Flint Men's Health Study (2006) (0)
- MP-09.16 (2006) (0)
- EARLY RECOVERY OF URINARY AND SEXUAL FUNCTION AFTER ROBOTIC-ASSISTED PROSTATECTOMY (2009) (0)
- Appraisal and quality of life of partners of prostate cancer survivors 24 months after treatment: (548132012-039) (2010) (0)
- Sexual Health Concerns Among Cancer Survivors: Testing a Novel Information-Need Measure Among Breast and Prostate Cancer Patients (2015) (0)
- Assessing quality of care for prostate cancer (2005) (0)
- Medical management of benign prostatic hyperplasia (2010) (0)
- Intra-Practice Urologist-Level Variation in Targeted Fusion Biopsy Outcomes. (2023) (0)
- 137 EVALUATION OF [-2]PROPSA IN COMBINATION WITH PSA AND FREE PSA, USING THE BECKMAN COULTER ACCESS IMMUNOASSAY SYSTEMS, FOR IDENTIFYING PATIENTS WITH AGGRESSIVE PROSTATE CANCER. A MULTI-CENTER PROSPECTIVE CLINICAL EVALUATION (2010) (0)
- EFFECT OF URINARY INCONTINENCE TREATMENT ON DEPRESSION SYMPTOMS (2011) (0)
- 207: Prostate Cancer Quality of Care: The American College of Surgeons Special Study (2006) (0)
- 379: Racial Disparities in Radical Cystectomy Resource Utilization (2004) (0)
- Projecting Bene fi ts and Harms of Novel Cancer Screening Biomarkers : A Study of PCA 3 and Prostate Cancer (2015) (0)
- COMPARISON OF BODY IMAGE BETWEEN ILEAL CONDUIT AND ORTHOTOPIC NEOBLADDER PATIENTS AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER (2009) (0)
- DEMOGRAPHIC AND CLINICAL PARAMETERS ASSOCIATED WITH USE OF MEDICAL THERAPY AT ENROLMENT IN THE BPH REGISTRY AND PATIENT SURVEY (2006) (0)
- Serum PDGF Decreases during Combined Radiation and Androgen Deprivation Therapy for Prostate Cancer (2009) (0)
- MP51-10 PREDICTORS OF FAVORABLE URINARY OUTCOMES AFTER PROSTATE CANCER TREATMENT (2014) (0)
- Abstract 4441: Informational needs of prostate cancer survivors: Findings from the Michigan Prostate Cancer Follow-Back Study (2012) (0)
- MP48-17 ANTERIOR PROSTATE CANCER: CLINICOPATHOLOGIC CHARACTERIZATION WITH BIOPSY CORRELATION (2015) (0)
- 123: Impact of Urinary Incontinence Severity on Mental Health (2004) (0)
- Abstract 4451: The NCI Early Detection Research Network (EDRN) urinary PCA3 validation trial (2012) (0)
- PD30-12 HOSPITAL COST VARIATION FOR KIDNEY TRANSPLANTATION (2014) (0)
- EMIGRATION FROM ASIA AND THE SUBSEQUENT RISK OF PROSTATE CANCER (1999) (0)
- 1773 LONGITUDINAL CHANGES IN URINARY INCONTINENCE SYMPTOM SEVERITY FOLLOWING TREATMENT IN WOMEN (2010) (0)
- Use of the "decoy" catheter to prevent traumatic foley removal (2005) (0)
- 176: Preoperative Risk Factors Associated with 30-Day Morbdity Following Urologic Surgery: The National Surgical Quality Improvement Program (2005) (0)
- 824: Neoadjuvant Hormone Therapy (NHT) Leads to Immediate Impairment of Vitality/Hormonal and Sexual Quality of Life: Results of a Multi-Center Prospective Study (2005) (0)
- DISCERNING RISK OF CLINICALLY SIGNIFICANT VERSUS INDOLENT PROSTATE CANCER PRIOR TO BIOPSY: PREDICTIVE MODEL FROM A MULTI-CENTER COHORT (2009) (0)
- 454: Attenuation of the Birth Cohort Effect in Testis Cancer (2006) (0)
- MP56-10 RETROSPECTIVE ANALYSIS OF THE PERFORMANCE OF MIPS IN PATIENTS HAVING HAD MULTI-PARAMETRIC MRI (2020) (0)
- Reply by the authors. (2013) (0)
- Assessment of urinary HRQOL in post-prostatectomy patients using epic A patient-reported validated instrument (2001) (0)
- 1305: Epidemiology of Surgically Treated Erectile Dysfunction in the United States from 1988 to 2002 (2006) (0)
- FIVE YEAR CHANGE IN URINARY INCONTINENCE AND IRRITATIVE SYMPTOMS AFTER PROSTATE CANCER TREATMENT MEASURED WITH A VALIDATED QUALITY OF LIFE QUESTIONNAIRE (2009) (0)
- Assessing quality of care in urologic surgery (2009) (0)
- PD44-07 EFFECTIVENESS OF SERUM PSA, URINE PCA3 AND URINE TMPRSS2:ERG FUSION AS A NOVEL URINARY BIOMARKER PANEL IN CLINICAL PRACTICE (2015) (0)
- 1660: The Regionalization of Percutaneous Nephrolithotomy to Specific Medical Centers: Evidence for Regionalization of a Low-Risk Procedure (2006) (0)
- CAN FREQUENCY OF PROSTATE BIOPSY ON ACTIVE SURVEILLANCE BE REDUCED WITHOUT SIGNIFICANTLY INCREASING RISK?: MP43‐01 (2017) (0)
- 5: Do Socioeconomic Characteristics Play a Role in Treatment Choice for BPH? (2006) (0)
- UIJ - Refractory idiopathic urge urinary incontinence and botulinum a injection (2008) (0)
- Abstract 929: Transcriptome sequencing identifies novel non-coding RNAs associated with prostate cancer progression (2011) (0)
- Learning Objective: At the conclusion of the continuing medical education activity, the participant will understand the basic evaluation and treatment of a patient with lower urinary tract symptoms as detailed in the AUA guideline for management of benign prostatic hyperplasia. (2013) (0)
- 1218 INCORPORATION OF BODY MASS INDEX AND PROSTATE SIZE INTO A NOMOGRAM FOR SELECTING PATIENTS FOR INITIAL PROSTATE BIOPSY: VALIDATION IN THE PROSTATE CANCER PREVENTION TRIAL (2012) (0)
- 266 USE OF BPH GUIDELINE RECOMMENDED CARE IN THE MEDICARE POPULATION (2010) (0)
- 990 PROGRESSION AND TREATMENT IN A MULTI-INSTITUTIONAL, PROSPECTIVE ACTIVE SURVEILLANCE STUDY: RESULTS FROM CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS) (2012) (0)
- UTILIZATION OF MEDICATIONS AND DEVICES FOR ERECTILE DYSFUNCTION AFTER PROSTATE CANCER TREATMENT: RESULTS FROM THE MULTICENTER PROSTQA CONSORTIUM (2009) (0)
- 1681: Temporal Trends in Percutaneous Sone Procedures (2005) (0)
- PROSPECTIVE MULTICENTER COMPARISON OF OPEN AND ROBOTIC RADICAL PROSTATECTOMY: THE PROST‐QA/RP2 CONSORTIUM: PD18‐08 (2017) (0)
- 465: Impact of Post-Prostatectomy Urethral Strictures on Urinary and Sexual Health Related Quality of Life (2006) (0)
- 1330: National Trends of Partial Nephrectomy for Renal Cell Carcinoma: A Case of Underutilization? (2005) (0)
- Association of declining PSA values with a lower risk of progression in the Canary Prostate Cancer Active Surveillance Study (PASS). (2013) (0)
- 231: Laparoscopic Nephrectomy: Prolonged Diffusion of a Standard of Care (2006) (0)
- 1383: The Impact of Contemporary Surgical Management on Inpatient Resource Utilization and Costs for Benign Prostatic Hyperplasia (2005) (0)
- DEVELOPMENT OF EXPANDED PROSTATE CANCER INDEX COMPOSITE (EPIC) SEXUAL FUNCTION DOMAIN GROUPS TO DEFINE SEVERITY OF SEXUAL DYSFUNCTION FOLLOWING RADICAL PROSTATECTOMY (2009) (0)
- Shock-Wave Lithotripsy for Renal Calculi (2012) (0)
- PD38-06 WHAT IS THE IDEAL NUMBER OF CORES TO COLLECT PER REGION OF INTEREST DURING TARGETED PROSTATE BIOPSY? (2023) (0)
- 386 PCA3 and T2-ERG add further predictive and clinical benefit to the detection of prostate cancer in men of various ages in the early detection research network (EDRN) (2016) (0)
- The Prostate 68 : 442 ^ 452 ( 2008 ) Pilot and Feasibility Studyof SerumChemokines as Markers toDistinguish ProstaticDisease inMenWith LowTotal SerumPSA (2008) (0)
- Development and Validation of a Quantitative Measure of Adaptive Behaviors in Women With Pelvic Floor Disorders. (2017) (0)
- 211: Risk Factors for Prolonged Length of Stay Following Urologic Surgery: The National Surgical Quality Improvement Program (2006) (0)
- Comparison of Health-Related Quality of Life Between Japanese and American Patients with Bladder Cancer as Measured by a Newly Developed Japanese Version of the Bladder Cancer Index (2020) (0)
- A Multi-institutional Phase 2 Trial Assessing Quality of Life (QOL) After Electromagnetic Transponder Guided Prostate Stereotactic Body Radiation Therapy (SBRT) (2015) (0)
- 206: Quality of Care for Localized Prostate Cancer: A Comparison of Radical Prostatectomy and External Beam Radiation from the National Cancer Data Base (2006) (0)
- Abstract B24: Common and persistent adverse outcomes following prostate cancer treatment: Findings from the Michigan Prostate Cancer Survivor Study (2011) (0)
- 850 PROSTATE CANCER DETECTION RATES, RISK FACTORS, AND DISTRIBUTION WITH TRANSPERINEAL MAPPING TEMPLATE PROSTATE BIOPSY: INITIAL SINGLE INSTITUTION EXPERIENCE (2011) (0)
- 440 DECREASING HOSPITAL LENGTH OF STAY FOR PROSTATECTOMY AND CYSTECTOMY. ARE WE NEARING A THRESHOLD (2011) (0)
- 1029: Racial Differences in Serum Prostate Specific Antigen (PSA) Doubling Time, Histopathological Variables and Long-Term PSA Recurrence Between African American and Willte American Men Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer (2004) (0)
- MP40-01 EVALUATION OF PRE-BIOPSY RECTAL SWABS, AUGMENTED ANTIBIOTICS, AND FORMALIN NEEDLE DISINFECTION ON RATES OF TRANSRECTAL PROSTATE BIOPSY COMPLICATIONS (2018) (0)
- MP24-18 HEALTH-RELATED QUALITY OF LIFE IN JAPANESE PATIENTS WITH BLADDER CANCER ACCORDING TO A NEWLY DEVELOPED JAPANESE VERSION OF THE BLADDER CANCER INDEX (2020) (0)
- 428 ADOPTION OF LASER TECHNOLOGY IS ASSOCIATED WITH INCREASED BPH SURGERY RATES (2012) (0)
- Overview Prostate cancer is the most commonly diagnosed The NCCN Prostate Cancer Early Detection Clinical Practice Guidelines in OncologyTM (2010) (0)
- 674: Apical Dissection Technique During Radical Retropubic Prostatectomy Influences Rate and Absolute Development of Postoperative Urinary Continence (2006) (0)
- MP04-19 BARRIERS TO ADOPTION AND EDUCATIONAL NEEDS REGARDING TRANSPERINEAL PROSTATE BIOPSY UNDER LOCAL ANESTHESIA (2020) (0)
- 2206 THE NCI EARLY DETECTION RESEARCH NETWORK (EDRN) URINARY PCA3 VALIDATION TRIAL (2012) (0)
- MP-09.19: Why men on watchful waiting for LUTS/BPH start medical therapy: findings from the USA BPH Registry & Patient Survey (2006) (0)
- Functional intrapelvic neuroanatomy of the male urethral sphincter assessed by intraoperative nerve stimulation (2002) (0)
- MP3-18 URINARY INCONTINENCE AFTER LASER PROSTATECTOMY FOR BPH – CONTEMPORARY EXPERIENCE (2015) (0)
- 45 A THEORETICAL MODEL FOR DIAGNOSTIC TEST ASSESSMENT AND ITS APPLICATION TO PROSTATE-SPECIFIC ANTIGEN TEST USE AMONG MEDICARE BENEFICIARIES (2011) (0)
- THE IMPACT OF BLADDER NECK SPARING AND NERVE SPARING ON URINARY FUNCTION AND CANCER CONTROL ASSOCIATED WITH RADICAL PROSTATECTOMY (1999) (0)
- 347: Level of Sexual Function is Adversely Affected by Urinary Incontinence (2004) (0)
- 499 UROLOGIST INTENSITY IN THE INITIAL EVALUATION OF ELDERLY MEN WITH BPH (2010) (0)
- 3: Adaptability of Physician Practice Style to the Technologic Imperative (2006) (0)
- Abstract 3207: Application of an antibody-free, highly sensitive PRISM-SRM proteomics approach for monitoring low abundance proteins and protein isoforms in cell lines and tumor tissue. (2013) (0)
- 1500: Health-Related Quality of Life is the Main Predictor of Progression to Benign Prostatic Hyperplasia Related Surgery: Outcomes Data from the BPH Registry & Patient Survey (2007) (0)
- 2158 COMBINING TMPRSS2:ERG AND PCA3 IN POST-DRE URINE WITH SERUM PSA TO IDENTIFY PROSTATE BIOPSY CANDIDATES: DEVELOPMENT AND VERIFICATION OF A CLINICALLY PRACTICAL ALGORITHM (2010) (0)
- 2215 TRANSPERINEAL MAPPING TEMPLATE PROSTATE BIOPSY AFTER PREVIOUS TRANSRECTAL ULTRASOUND PROSTATE BIOPSY DETECTS WORSE DISEASE BURDEN (2013) (0)
- 41 UNDERSTANDING THE COMPARATIVE EFFECTIVENESS OF LAPAROSCOPIC RADICAL NEPHRECTOMY FOR PATIENTS WITH KIDNEY CANCER (2011) (0)
- Screening and Health Transition (2013) (0)
- CLINICOPATHOLOGIC CHARACTERISTICS OF PATIENTS WITH VERY LOW‐RISK (PI‐RADS 1 OR 2) LESIONS BY MULTIPARAMETRIC PROSTATE MAGNETIC RESONANCE IMAGING: MP38‐17 (2017) (0)
- Editorial comment. (2013) (0)
- 178: National Trends in the Utilization and Outcomes of Cystectomy (2005) (0)
- PD30-11 INITIAL PATIENT REPORTED OUTCOMES FOR MEN WITH PROSTATE CANCER UNDERGOING RECTAL HYDROGEL SPACER PLACEMENT UNDER LOCAL ANESTHESIA (2020) (0)
- Long-Term Symptom Improvement in Women After Fecal Incontinence Treatments: A Multicenter Cohort Study of the Pelvic Floor Disorders Network (2011) (0)
- Convalescence And Recovery Evaluation (2016) (0)
- PREDICTING URINARY FUNCTION AFTER PROSTATE CANCER TREATMENT: A MULTIVARIABLE NOMOGRAM FROM THE PROSTQA CONSORTIUM (2009) (0)
- 905: The Prevalence and Outcome of Therapy for Erectile Dysfunction 4 to 8 Years Following Brachytherapy, External Radiation and Radical Prostatectomy for Localized Prostate Cancer (2004) (0)
- Abstract 2483: An antibody-independent, complementary SRM strategy for ultrasensitive and multiplexed quantification of cancer biomarker candidates (2014) (0)
- Commentary on bupivacaine for anesthesia in transrectal prostate biopsy (2005) (0)
- The Urologic Diseases in America project: an opportunity for introspection (2005) (0)
- QUALITY OF CARE AMONG MEN WITH NEWLY DIAGNOSED BENIGN PROSTATIC HYPERPLASIA AND LOWER URINARY TRACT SYMPTOMS IN A MANAGED CARE SETTING (2008) (0)
- PD08-12 PROGNOSTIC VALUE OF PERCENT GLEASON GRADE 4 IN PROSTATE BIOPSY SPECIMENS AFTER RADICAL PROSTATECTOMY (2016) (0)
- THE QUALITY OF ACTIVE SURVEILLANCE FOR MEN WITH LOW-RISK PROSTATE CANCER (2009) (0)
- Finding the Nearest TRexit: Novel Transperineal Prostate Biopsy Approaches for All Practices (2020) (0)
- 1799: The Relationship Between Extended Pattern Prostate Biopsy and Clinically Insignificant Prostate Cancer (2004) (0)
- The Michigan Incontinence Symptom Index (M-ISI): A clinical measure for type, severity, and bother related to urinary incontinence: Editorial comment (2015) (0)
- 1605: Prostate Cancer Physician Performance Measured by Patient-Reported Ratings of Practitioner Manner/Skill and by Treatment-Related Adverse Events (2006) (0)
- MP30-08 BARRIERS TO ADOPTION AND IMPLEMENTATION OF TRANSPERINEAL PROSTATE BIOPSY UNDER LOCAL ANESTHESIA (2021) (0)
- Comprehensive Comparison of Heal th-Related Qual i ty of Li fe Af ter Contemporary Therapies for Local ized Prostate Cancer (2001) (0)
- 1566: BPH Management in an HMO Setting: Differences between Primary Care Physicians and Urologists (2007) (0)
- 72: Quality of Life and Patient Satisfaction of Care Among Women with Urinary Incontinence: A Prospective Study (2007) (0)
- ORAL POSTER 4: Comparative Analysis of Urinary Incontinence Severity After Pubovaginal Sling or Tension Free Vaginal Tape (2005) (0)
- 1671: Association of Race, Cancer Severity, Pre-Treatment Quality of Life, and Patient Optimism/Pessimism with Patient Selection of Primary Prostate Cancer Treatment (2005) (0)
- 1130 : Should PNI Be Included for Risk-Stratification of Prostate Cancer? (2006) (0)
- 694 ALLEVIATION VERSUS INDUCTION OF URINARY OBSTRUCTION OR INCONTINENCE BY PROSTATE CANCER TREATMENT THE PIVOTAL ROLE OF PRETREATMENT URINARY SYMPTOMS (2012) (0)
- 1703: Noninvasive Detection of TMPRSS2:Erg Fusion Transcripts in the Urine of Men with Prostate Cancer (2007) (0)
- Abstract 914: Development of a whole-urine, next-generation sequencing-based assay for early detection of aggressive prostate cancer (2019) (0)
- Cause-specific survival is high following radiotherapy or surgery for Gleason score 8–10 prostate cancer (2004) (0)
- MP-09.18 : Use of alternative therapies by men enrolled in the USA BPH Registry & Patient Survey (2006) (0)
- Quantification Of The Heterogeneity In Hydrogel Rectal Spacer Volume And Impact On Spacer And Rectal Dosimetry (2020) (0)
- 850: The Use of Autoantibody Signatures for the Prediction of Prostate Cancer Gleason Score (2006) (0)
- 35: Evolution of Outpatient Care for Benign Prostatic Hyperplasia in the 1990s: Data from the Urologic Diseases in America Project (2005) (0)
- MP35-19 ASSOCIATION OF URINARY PCA3 AND TMPRSS2:ERG RISK GROUPS WITH DETECTION OF PROSTATE CANCER AT REPEAT BIOPSY IN MEN WITH AN INITIAL NEGATIVE PROSTATE BIOPSY (2018) (0)
- Oral Poster 47: Factors Correlated with Urge Urinary Incontinence Following Surgery for Stress Incontinence (2004) (0)
- 431: Utilization of Ambulatory Surgery Centers by Urologists (2007) (0)
- PD19-11 INDIVIDUALIZED PROSTATE CANCER RISK ASSESSMENT BY SERUM PSA, URINE TMPRSS2:ERG AND URINE PCA3 (2014) (0)
- 676: Obesity Affects Health Related Quality of Life at Baseline Before and in Recovery after Radical Retropubic Prostatectomy (2005) (0)
- 318 CHANGES IN INITIAL EXPENDITURES FOR BENIGN PROSTATIC HYPERPLASIA EVALUATION IN THE MEDICARE POPULATION (2011) (0)
- 443: Sexual Behavior, Sexually Transmitted Diseases, and the Risk of Prostate Cancer in African American Men: The Flint Men’s Health Study (2004) (0)
- 177: Incremental Risk of Mortality Associated with Multiple Complications Following Bladder Cancer Surgery (2005) (0)
- 870: Laparoscopy for Renal Cell Carcinoma: Diffusion Versus Regionalization of a New Standard of Care? (2006) (0)
- Patient-Reported Outcomes for Quality of Life (QOL) by Expanded Prostate Cancer Index (EPIC) 15 Years Posttreatment (2014) (0)
- BCL-2 AND P53 EXPRESSION IN CLINICALLY LOCALIZED PROSTATE CANCER PREDICTS THE RESPONSE OF PATIENTS TO EXTERNAL BEAM RADIOTHERAPY (1999) (0)
- MP71-06 ASSOCIATION OF AUA-SS SUBSCALES WITH POST LASER PROSTATECTOMY URINARY INCONTINENCE (2015) (0)
- 1: Determinants of Satisfaction with Outcome in a Prospective, Multi-Center Study of Prostatectomy, External Radiotherapy, or Brachytherapy for Early Stage Prostate Cancer (2007) (0)
- Quality assurance in urologic oncology: a radical prostatectomy experience of 2254 cases (2005) (0)
- 1407: Measuring Anti-Amacr Humoral Response as a Serum Assay to Distinguish Aggressive from Indolent Prostate Cancer (2005) (0)
- EFFECT OF PHOSPHODIESTERASE TYPE 5 INHIBITOR (PDE5I) USE ON LOWER URINARY TRACT SYMPTOMS (LUTS) OVER TIME AMONG MEN ON WATCHFUL WAITING VERSUS BPH MEDICAL THERAPY: RESULTS FROM THE BPH REGISTRY (2009) (0)
- Rational Approach to Implementation of PCA 3 into Clinical Care (2011) (0)
- Clinical Assessment and Diagnosis of Lower Urinary Tract Dysfunction (2014) (0)
- PD15-02 LONG-TERM HEALTH RELATED QUALITY OF LIFE IN PROSTATE CANCER PATIENTS REQUIRING RADIOTHERAPY AFTER RADICAL PROSTATECTOMY (2023) (0)
- 557: Adoption of New Technology and Health Care Quality: Surgical Margins Following Robotic Prostatectomy (2007) (0)
- 183: Quality of Bladder Cancer care and the Utilization of Partial Cystectomy: A case of Inappropriate use? (2005) (0)
- DISCRIMINATION OF CARE TO PATIENT DIFFERENCES: A USEFUL TOOL FOR EVALUATING QUALITY? (2008) (0)
- 1488: Complications Following Surgical Intervention for Urinary Incontinence in Men: A National Perspective (2007) (0)
- PREDICTING ERECTION RECOVERY AFTER PROSTATECTOMY: A MULTIVARIABLE NOMOGRAM FROM THE PROSTQA CONSORTIUM (2009) (0)
- 675: Early Urinary Retention After Catheter Removal Following Radical Prostatectomy is Associated with Future Urethral Stricture Formation (2006) (0)
- Metabolite biomarkers of prostate cancer (2008) (0)
- Two Specialists, Two Recommendations: Discordance between Urologists' & Radiation Oncologists' Prostate Cancer Treatment Recommendations. (2022) (0)
- CLINICOPATHOLOGIC CHARACTERISTICS OF PATIENTS UNDERGOING PROSTATE CORE BIOPSY WITH HIGH‐RISK (PI‐RADS 5) LESIONS BY MULTIPARAMETRIC PROSTATE MAGNETIC RESONANCE IMAGING.: MP38‐18 (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With John Thomas Wei?
John Thomas Wei is affiliated with the following schools:
